Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003222
Status:
COMPLETED
Last Update Posted:
2014-12-19
First Post:
1999-11-01
Brief Title:
Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
Sponsor:
University of Virginia
Organization:
University of Virginia
Organization Data
Organization:
University of Virginia
Class:
OTHER
Study ID:
7621
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Virginia
Lead Sponsor Class:
OTHER
Responsible Party:
Craig L Slingluff Jr
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Virginia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |